BIOMAT Database Logo BIOMAT Database Logo

Detection of human glandular kallikrein, hK2, as its precursor form and in complex with protease inhibitors in prostate carcinoma serum. 1998

L S Grauer, and J A Finlay, and S D Mikolajczyk, and K D Pusateri, and R L Wolfert
Hybritech Incorporated, a subsidiary of Beckman Instruments, Incorporated, San Diego, California 92196-9006, USA.

Forms of human glandular kallikrein (kK2) in prostate carcinoma serum were identified using monoclonal antibodies specific for hK2 and prohK2. Recombinant mammalian hK2, prohK2, and prostate = specific antigen (PSA) were utilized to confirm the specificity of monoclonal antibodies for hK2 and the lack of reactivity with PSA. In prostate cancer patient sera containing high levels of hK2 (>100 ng/ml), hK2 exists as a complex with alpha1-antichymotrypsin with a molecular weight of 90 kDa. The kallikrein also exists as a 32-kDa free form, which includes the precursor pro form of hK2. The relative amount of complex and free hK2 varied, but in most sera examined the 32-kDa form predominated. Recombinant hK2 readily formed complexes with alpha2-macroglobulin when the two proteins were incubated together as well as when hK2 was spiked into female serum.

UI MeSH Term Description Entries
D007610 Kallikreins Proteolytic enzymes from the serine endopeptidase family found in normal blood and urine. Specifically, Kallikreins are potent vasodilators and hypotensives and increase vascular permeability and affect smooth muscle. They act as infertility agents in men. Three forms are recognized, PLASMA KALLIKREIN (EC 3.4.21.34), TISSUE KALLIKREIN (EC 3.4.21.35), and PROSTATE-SPECIFIC ANTIGEN (EC 3.4.21.77). Kallikrein,Kininogenase,Callicrein,Dilminal,Kallidinogenase,Kalliginogenase,Kallikrein A,Kallikrein B',Kallikrein Light Chain,Kinin-Forming Enzyme,Padutin,alpha-Kallikrein,beta-Kallikrein,beta-Kallikrein B,Enzyme, Kinin-Forming,Kinin Forming Enzyme,Light Chain, Kallikrein,alpha Kallikrein,beta Kallikrein,beta Kallikrein B
D008297 Male Males
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings
D015592 Immunoradiometric Assay Form of radioimmunoassay in which excess specific labeled antibody is added directly to the test antigen being measured. Assay, Immunoradiometric,Assays, Immunoradiometric,Immunoradiometric Assays

Related Publications

L S Grauer, and J A Finlay, and S D Mikolajczyk, and K D Pusateri, and R L Wolfert
Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors.
January 1998, The Prostate,
L S Grauer, and J A Finlay, and S D Mikolajczyk, and K D Pusateri, and R L Wolfert
Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer.
March 2006, International journal of urology : official journal of the Japanese Urological Association,
L S Grauer, and J A Finlay, and S D Mikolajczyk, and K D Pusateri, and R L Wolfert
Prostate-specific antigen (hK3) and human prostatic glandular kallikrein (hK2) in the detection of early stage human prostate cancer.
April 1998, The Journal of laboratory and clinical medicine,
L S Grauer, and J A Finlay, and S D Mikolajczyk, and K D Pusateri, and R L Wolfert
Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitors.
June 1999, European journal of biochemistry,
L S Grauer, and J A Finlay, and S D Mikolajczyk, and K D Pusateri, and R L Wolfert
The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
December 1998, Cancer,
L S Grauer, and J A Finlay, and S D Mikolajczyk, and K D Pusateri, and R L Wolfert
Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levels.
March 1997, Urology,
L S Grauer, and J A Finlay, and S D Mikolajczyk, and K D Pusateri, and R L Wolfert
Complex formation between human kallikrein 13 and serum protease inhibitors.
January 2004, Clinica chimica acta; international journal of clinical chemistry,
L S Grauer, and J A Finlay, and S D Mikolajczyk, and K D Pusateri, and R L Wolfert
Expression of human glandular kallikrein, hK2, in mammalian cells.
December 1996, Cancer research,
L S Grauer, and J A Finlay, and S D Mikolajczyk, and K D Pusateri, and R L Wolfert
Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
January 1999, Journal of andrology,
L S Grauer, and J A Finlay, and S D Mikolajczyk, and K D Pusateri, and R L Wolfert
Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.
January 2000, The Journal of urology,
Copied contents to your clipboard!